Workflow
大行评级丨里昂:药明康德第三季业绩表现稳健 上调AH股目标价并维持“跑赢大市”评
Ge Long Hui·2025-10-27 02:41

Core Viewpoint - WuXi AppTec's Q3 performance was robust, with revenue, net profit, and order growth exceeding market expectations [1] Financial Performance - Revenue and adjusted non-IFRS net profit increased by 15% and 42% year-on-year, respectively [1] - The company raised its full-year revenue growth guidance from 13%-17% to 17%-18% [1] - The adjusted non-IFRS net profit margin is expected to further improve year-on-year [1] Future Projections - The revenue and net profit forecasts for WuXi AppTec for 2025 to 2027 were increased by approximately 2% and 4%, respectively, reflecting the strong Q3 performance and continued robust order growth [1] Target Price Adjustments - The target price for WuXi AppTec's H-shares was raised from HKD 137.1 to HKD 138.6, and the A-shares target price was increased from CNY 124.7 to CNY 126 [1] - The rating remains "Outperform" and the shares are considered a top pick in the domestic CRO and CDMO sectors [1]